How To Prevent Data Integrity Warning Letters
Source: Pharmaceutical Online

Failures in data governance and data integrity continue to be addressed in approximately 80% of FDA warning letters issued to domestic and foreign sites. This ebook explores insights and strategies from experts in the field, including:
- An Analysis of FDA Warning Letters
- Is GMP Quality System Auditing Fundamentally Flawed?
- Managing GxP Environmental Systems To Ensure Data Integrity
- 5 Steps To Build A Quality Culture That Supports Data Integrity
- The 5 Basic Tenets of Data Integrity - And How Failures Occur
access the E-Book!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online